Related Experiment Video
Updated: May 13, 2026
05:55
Tension-Free Weight-Bearing Model of Steroid-Induced Osteonecrosis of Femoral Head in Rats
Published on: September 27, 2024
β-1 adrenergic agonist mitigates unloading-induced bone loss by maintaining formation
Joshua M Swift1, Harry A Hogan, Susan A Bloomfield
1Department of Health and Kinesiology, Texas A&M University, College Station, TX, USA.
Medicine and Science in Sports and Exercise
|March 9, 2013
Summary
Beta-1 adrenergic agonist dobutamine (DOB) prevents bone loss during hindlimb unloading (HU) in rats by improving bone formation. DOB
Area of Science:
- Bone physiology
- Adrenergic signaling
- Skeletal adaptation
Background:
- Sympathetic nervous system influences bone metabolism.
- Hindlimb unloading (HU) causes disuse-induced bone loss.
- Beta-1 adrenergic (Adrb1) agonists may impact bone integrity.
Purpose of the Study:
- To evaluate dobutamine's (DOB) effects on bone integrity during hindlimb unloading (HU).
- To investigate Adrb1 signaling's role in disuse osteopenia.
Main Methods:
- Male Sprague-Dawley rats underwent 28 days of hindlimb unloading (HU) or cage control (CC).
- Animals received daily dobutamine (DOB) or saline (VEH) injections.
- Bone integrity was assessed using peripheral quantitative computed tomography (pQCT) and bone formation rate measurements.
Main Results:
- HU induced a 9% loss in proximal tibia metaphysis (PTM) volumetric bone mineral density (vBMD).
- DOB administration during HU significantly attenuated vBMD loss and preserved bone structure.
- DOB abolished the decline in PTM bone formation rate and prevented reductions in femoral strength.
Conclusions:
- Dobutamine (DOB) effectively mitigates bone loss and preserves bone strength during hindlimb unloading (HU).
- DOB acts by improving bone formation rate, specifically in unloaded bone.
- Adrenergic signaling via Adrb1 is crucial for maintaining osteoblast function during mechanical unloading.
Related Concept Videos
01:40Bone Remodeling
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
01:31Osteoclasts in Bone Remodeling
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
01:29Bone Disorders
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
01:31Adrenergic Antagonists: ɑ and β-Receptor Blockers
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is clinically...
01:17Hormones and Bone Tissue
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
01:27Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in bronchial smooth...